E-cigarettes to assist with smoking cessation

New England Journal of Medicine

Volumn 380, Issue 7, 2019, Pages 678-679

  Borrelli, Belinda ^a   O'Connor, George T ^b  

^a BOSTON UNIVERSITY   (United States)

^b BOSTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHILD DEVELOPMENT; EDITORIAL; FOOD AND DRUG ADMINISTRATION; HIGH RISK POPULATION; NICOTINE REPLACEMENT THERAPY; OUTCOME ASSESSMENT; PREGNANCY OUTCOME; PREVALENCE; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; RISK FACTOR; SMOKING CESSATION; SMOKING CESSATION PROGRAM; UNITED KINGDOM; UNITED STATES; ELECTRONIC CIGARETTE; HUMAN; SMOKING PREVENTION; TOBACCO DEPENDENCE;

NICOTINE;

ELECTRONIC NICOTINE DELIVERY SYSTEMS; HUMANS; NICOTINE; SMOKING CESSATION; SMOKING PREVENTION; TOBACCO USE DISORDER;

EID: 85061580832     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMe1816406     Document Type: Editorial

References (13)

1. Wang TW, Asman K, Gentzke AS, et al. Tobacco product use among adults - United States, 2017. MMWR Morb Mortal Wkly Rep 2018;67:1225-32.
2. Borrelli B, Busch A, Dunsiger S. Cigarette smoking among adults with mobility impairments: a US population-based survey. Am J Public Health 2014;104:1943-9.
3. Benmarhnia T, Pierce JP, Leas E, et al. Can e-cigarettes and pharmaceutical aids increase smoking cessation and reduce cigarette consumption? Findings from a nationally representative cohort of American smokers. Am J Epidemiol 2018;187:2397-404.
4. Hajek P, Phillips-Waller A, Przulj D, et al. A randomized trial of e-cigarettes versus nicotine-replacement therapy. N Engl J Med 2019;380:629-37.
5. Rosen LJ, Galili T, Kott J, Goodman M, Freedman LS. Diminishing benefit of smoking cessation medications during the first year: a meta-analysis of randomized controlled trials. Addiction 2018;113:805-16.
6. Windle SB, Filion KB, Mancini JG, et al. Combination therapies for smoking cessation: a hierarchical bayesian meta-analysis. Am J Prev Med 2016;51:1060-71.
7. Anthenelli RM, Benowitz NL, West R, et al. Neuropsychi-atric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial. Lancet 2016;387:2507-20.
8. Polosa R, Morjaria JB, Caponnetto P, et al. Evidence for harm reduction in COPD smokers who switch to electronic cigarettes. Respir Res 2016;17:166.
9. Cooper S, Taggar J, Lewis S, et al. Effect of nicotine patches in pregnancy on infant and maternal outcomes at 2 years: followup from the randomised, double-blind, placebo-controlled SNAP trial. Lancet Respir Med 2014;2:728-37.
10. Stratton K, Kwan LY, Eaton DL, eds. Public health consequences of e-cigarettes. Washington, DC: National Academies Press, January 2018.
11. Ghosh A, Coakley RC, Mascenik T, et al. Chronic e-cigarette exposure alters the human bronchial epithelial proteome. Am J Respir Crit Care Med 2018;198:67-76.
12. Garcia-Arcos I, Geraghty P, Baumlin N, et al. Chronic electronic cigarette exposure in mice induces features of COPD in a nicotine-dependent manner. Thorax 2016;71:1119-29.
13. Stein R. Surgeon General warns youth vaping is now an “epidemic.” NPR. December 18, 2018 (https://www.npr.org/sections/health-shots/2018/12/18/677755266/surgeon-general-warns-youth -vaping-is-now-an-epidemic).